Physician profile
Jonathan M Moore
NPI 1063670602
$2,811.81
in general payments reported to CMS, 2019-2025
15 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $600 · 2020: $23.91 · 2021: $1,368 · 2022: $318 · 2023: $76.37 · 2024: $324 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $501.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Legacy Ortho LLC | $1,200.00 | 2021 | |
| Stryker Corporation | $696.98 | 2019-2022 | |
| Organogenesis INC. | $242.78 | 2019 | |
| Kerecis Limited | $220.81 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Treace Medical Concepts, INC. | $97.66 | 2022-2023 | |
| Exact Sciences Corporation | $68.85 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Clinical Technology, INC | $65.00 | 2019-2022 | |
| Abbvie INC. | $53.28 | 2025 | |
| Novo Nordisk INC | $29.67 | 2024 | Rybelsus, Ozempic |
| Cepheid | $28.50 | 2024 | Genexpert |
| Nevro Corp. | $24.72 | 2023 | Senza |
| Smith+Nephew, INC. | $24.44 | 2025 | Collagenase Santyl |
| Misonix INC | $23.91 | 2020 | |
| Lilly USA, LLC | $20.08 | 2023 | Jardiance |
| Bioventus LLC | $15.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.